Log in

Galectin Therapeutics News Headlines (NASDAQ:GALT)

$3.82
-0.18 (-4.50 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$3.80
Now: $3.82
$3.98
50-Day Range
$3.20
MA: $3.70
$4.17
52-Week Range
$2.94
Now: $3.82
$6.16
Volume166,505 shs
Average Volume283,676 shs
Market Capitalization$216.33 million
P/E RatioN/A
Dividend YieldN/A
Beta3

Headlines

Galectin Therapeutics (NASDAQ GALT) News Headlines

Source:
DateHeadline
Galectin Therapeutics Inc. (NASDAQ:GALT) Major Shareholder Fund L.P. 10X Sells 17,000 SharesGalectin Therapeutics Inc. (NASDAQ:GALT) Major Shareholder Fund L.P. 10X Sells 17,000 Shares
www.americanbankingnews.com - October 15 at 8:46 AM
 Analysts Anticipate Galectin Therapeutics Inc. (NASDAQ:GALT) to Announce -$0.06 EPS Analysts Anticipate Galectin Therapeutics Inc. (NASDAQ:GALT) to Announce -$0.06 EPS
www.americanbankingnews.com - September 29 at 11:25 AM
Galectin Therapeutics and Providence Cancer Institute nabs new patent in U.S.Galectin Therapeutics and Providence Cancer Institute nabs new patent in U.S.
seekingalpha.com - September 17 at 11:34 AM
Galectin Therapeutics and Providence Cancer Institute nab new patent in U.S.Galectin Therapeutics and Providence Cancer Institute nab new patent in U.S.
seekingalpha.com - September 17 at 11:34 AM
Galectin Therapeutics, Inc. and Providence Cancer Institute Receive Patent on the Use of Belapectin (GR-MD-02) in Cancer ImmunotherapyGalectin Therapeutics, Inc. and Providence Cancer Institute Receive Patent on the Use of Belapectin (GR-MD-02) in Cancer Immunotherapy
finance.yahoo.com - September 17 at 11:34 AM
Need To Know: Galectin Therapeutics, Inc. (NASDAQ:GALT) Insiders Have Been Buying SharesNeed To Know: Galectin Therapeutics, Inc. (NASDAQ:GALT) Insiders Have Been Buying Shares
finance.yahoo.com - August 27 at 10:27 PM
Galectin holders file to offer up to 1.7M sharesGalectin holders file to offer up to 1.7M shares
seekingalpha.com - August 10 at 5:38 AM
Galectin Therapeutics Submits Phase 3 NASH-RX Protocol in Nash Cirrhosis to FDAGalectin Therapeutics Submits Phase 3 NASH-RX Protocol in Nash Cirrhosis to FDA
finance.yahoo.com - August 5 at 8:53 AM
Galectin Therapeutics Raises $44.5 Million in Rights Offering and $2.5 Million from Warrant ExerciseGalectin Therapeutics Raises $44.5 Million in Rights Offering and $2.5 Million from Warrant Exercise
finance.yahoo.com - May 28 at 9:32 AM
What Type Of Shareholder Owns Galectin Therapeutics, Inc.'s (NASDAQ:GALT)?What Type Of Shareholder Owns Galectin Therapeutics, Inc.'s (NASDAQ:GALT)?
finance.yahoo.com - May 27 at 5:41 PM
Galectin sets lower price in rights offeringGalectin sets lower price in rights offering
seekingalpha.com - May 24 at 8:00 AM
Galectin Therapeutics Reports Alternate Price of Common Stock in Rights OfferingGalectin Therapeutics Reports Alternate Price of Common Stock in Rights Offering
finance.yahoo.com - May 23 at 7:43 PM
Galectin Therapeutics: Primed For Takeoff After The Rights Offering And New Clinical EvidenceGalectin Therapeutics: Primed For Takeoff After The Rights Offering And New Clinical Evidence
seekingalpha.com - May 15 at 5:49 PM
Galectin Therapeutics misses by $0.06Galectin Therapeutics misses by $0.06
seekingalpha.com - May 10 at 9:57 AM
Galectin Therapeutics Reports Q1 2019 Financial Results and Provides Business UpdateGalectin Therapeutics Reports Q1 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 10 at 9:57 AM
Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders Dated May 10, 2019Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders Dated May 10, 2019
finance.yahoo.com - May 10 at 9:57 AM
Galectin Therapeutics Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of its Registration StatementGalectin Therapeutics Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of its Registration Statement
finance.yahoo.com - April 15 at 8:06 AM
Galectin Therapeutics And Belapectin In Phase 3 NASH Cirrhosis: Moving UpGalectin Therapeutics And Belapectin In Phase 3 NASH Cirrhosis: Moving Up
seekingalpha.com - April 11 at 5:42 PM
The Galectin SignatureThe Galectin Signature
seekingalpha.com - April 9 at 8:00 AM
Galectin readies subscription rights offeringGalectin readies subscription rights offering
seekingalpha.com - April 8 at 8:10 PM
Galectin Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences ConferenceGalectin Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 2 at 1:01 PM
Galectin Therapeutics, Inc. (GALT)Galectin Therapeutics, Inc. (GALT)
finance.yahoo.com - April 1 at 5:23 PM
Providence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular BiologyProvidence Cancer Institute to Present Findings on GR-MD-02 at the 2019 Keystone Symposia on Molecular and Cellular Biology
finance.yahoo.com - March 22 at 10:26 AM
Galectin Therapeutics IncGalectin Therapeutics Inc
www.bloomberg.com - March 19 at 10:36 AM
Galectin Therapeutics Inc. Estimate MomentumGalectin Therapeutics Inc. Estimate Momentum
www.nasdaq.com - March 18 at 5:46 PM
Galectin In NASH, And The Market AssessmentGalectin In NASH, And The Market Assessment
seekingalpha.com - March 15 at 5:48 PM
Investors Who Bought Galectin Therapeutics Shares Three Years Ago Are Now Up 248%Investors Who Bought Galectin Therapeutics Shares Three Years Ago Are Now Up 248%
finance.yahoo.com - March 6 at 5:52 PM
BRIEF-Galectin Therapeutics Files For Offering Of Units To Purchase Common Shares Of Up To $75 MlnBRIEF-Galectin Therapeutics Files For Offering Of Units To Purchase Common Shares Of Up To $75 Mln
www.msn.com - March 6 at 9:58 AM
Galectin files for rights offering; shares down 1% premarketGalectin files for rights offering; shares down 1% premarket
seekingalpha.com - March 6 at 9:58 AM
Galectin Therapeutics Files Registration Statement for Stockholder Rights Offering of Common Stock and WarrantsGalectin Therapeutics Files Registration Statement for Stockholder Rights Offering of Common Stock and Warrants
finance.yahoo.com - March 6 at 9:58 AM
Galectin Therapeutics Releases Richard E. Uihlein’s Open Letter to StockholdersGalectin Therapeutics Releases Richard E. Uihlein’s Open Letter to Stockholders
finance.yahoo.com - March 6 at 9:58 AM
Galectin Therapeutics Likely To Appreciate On Clinical Results, Further PartnershipsGalectin Therapeutics Likely To Appreciate On Clinical Results, Further Partnerships
seekingalpha.com - February 20 at 5:45 PM
Gileads MousetrapGilead's Mousetrap
seekingalpha.com - February 15 at 9:53 AM
AVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDAAVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDA
finance.yahoo.com - February 1 at 5:40 PM
Is Galectin Therapeutics (GALT) Stock Outpacing Its Medical Peers This Year?Is Galectin Therapeutics (GALT) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - January 30 at 5:27 PM
Galectin Therapeutics’ Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Streamlining Its Capital StructureGalectin Therapeutics’ Largest Institutional Shareholder Converts Existing Series B Preferred Stock Into Common Stock Streamlining Its Capital Structure
finance.yahoo.com - January 15 at 9:11 AM
Did Galectin Therapeutics, Inc. (NASDAQ:GALT) Insiders Sell Shares?Did Galectin Therapeutics, Inc. (NASDAQ:GALT) Insiders Sell Shares?
finance.yahoo.com - December 25 at 5:17 PM
Form 8-K GALECTIN THERAPEUTICS For: Dec 20 - StreetInsider.comForm 8-K GALECTIN THERAPEUTICS For: Dec 20 - StreetInsider.com
www.streetinsider.com - December 21 at 8:27 AM
Galectin Therapeutics Announces Extension of $10 Million Line Credit - GlobeNewswireGalectin Therapeutics Announces Extension of $10 Million Line Credit - GlobeNewswire
globenewswire.com - December 21 at 8:27 AM
BRIEF-Galectin Announces Extension Of $10 Million Line CreditBRIEF-Galectin Announces Extension Of $10 Million Line Credit
www.msn.com - December 20 at 5:34 PM
Galectin Therapeutics Announces Extension of $10 Million Line CreditGalectin Therapeutics Announces Extension of $10 Million Line Credit
finance.yahoo.com - December 20 at 8:42 AM
GALECTIN THERAPEUTICS INC.GALECTIN THERAPEUTICS INC.
www.streetinsider.com - November 14 at 8:00 AM
Galectin Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business UpdateGalectin Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business Update
finance.yahoo.com - November 13 at 8:01 AM
Galectin up 10% on upcoming data presentation supporting utility of breath test in NASHGalectin up 10% on upcoming data presentation supporting utility of breath test in NASH
seekingalpha.com - November 5 at 5:31 PM
Galectin Therapeutics to Participate in The ROTH Capital Battle of the NASH Thrones Investment ConferenceGalectin Therapeutics to Participate in The ROTH Capital Battle of the NASH Thrones Investment Conference
feeds.benzinga.com - October 15 at 10:49 AM
Galectin Therapeutics to Present at The ROTH Capital Battle of the NASH Thrones Investment ConferenceGalectin Therapeutics to Present at The ROTH Capital Battle of the NASH Thrones Investment Conference
finance.yahoo.com - October 15 at 8:13 AM
Market Trends Toward New Normal in Altra Industrial Motion, IDEXX Laboratories, BioTelemetry, Galectin Therapeutics, NETGEAR, and Merck & Co. — Emerging Consolidated Expectations, Analyst RatingsMarket Trends Toward New Normal in Altra Industrial Motion, IDEXX Laboratories, BioTelemetry, Galectin Therapeutics, NETGEAR, and Merck & Co. — Emerging Consolidated Expectations, Analyst Ratings
finance.yahoo.com - October 11 at 8:01 AM
Form 424B3 GALECTIN THERAPEUTICSForm 424B3 GALECTIN THERAPEUTICS
www.streetinsider.com - September 26 at 5:12 PM
Galectins GR-MD-02 Positive in Phase Ib Study With KeytrudaGalectin's GR-MD-02 Positive in Phase Ib Study With Keytruda
www.msn.com - September 21 at 5:09 PM
Your Cancer Highlight: Galectin Surprises With Early-Stage Collaborative DataYour Cancer Highlight: Galectin Surprises With Early-Stage Collaborative Data
seekingalpha.com - September 21 at 5:09 PM
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: Market Timing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel